California-based psychedelic biotechnology company Freedom Biosciences has secured an undisclosed sum of investment from venture capital firm LongeVC. This investment follow’s Freedom Biosciences’ seed funding round in August 2022 which raised USD 10.5 million.
The use of funds has not been disclosed.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.